Enterprise Tech Ecosystem Series - GlaxoSmithKline plc
Summary
GlaxoSmithKline Plc (GSK) is one of the leading research-based pharmaceutical and healthcare companies in the world. The company is engaged in research, development and manufacturing of novel medicines, vaccines and consumer healthcare products.
Scope
The report provides information and insights into GlaxoSmithKline plc , including -
Reasons to Buy
Summary
GlaxoSmithKline Plc (GSK) is one of the leading research-based pharmaceutical and healthcare companies in the world. The company is engaged in research, development and manufacturing of novel medicines, vaccines and consumer healthcare products.
Scope
The report provides information and insights into GlaxoSmithKline plc , including -
- Insights of its digital transformation strategies
- Details of various innovation programs, partnerships, in-house launches, and other industry engagement programs
- Details of investments into various disruptive technologies
- Detailed overview of GlaxoSmithKline plc's financial highlights.
Reasons to Buy
- Gain insights into GlaxoSmithKline Plc technology innovations.
- Gain insights into its strategy and investment portfolio.
- Gain insights into various product launches, partnership strategies and investments of GlaxoSmithKline Plc.
- Gain insights into various disruptive technologies, digital transformation initiatives, partnerships and tech initiatives of the Company.
Table of Contents
- Overview
- Digital Transformation Strategy
- Disruptive Tech Theme Map
- Technology Initiatives
- Key Executives
- Venture Arm-SR One
- SR One Investments
- Action Potential Venture Capital (APVC) Venture Arm
- ICT Budget & Contracts
- Investor - Partner Network Map
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Cloud Pharmaceuticals
- Insilico Medicine
- Exscientia
- Cisco
- Cloudera
